Tamoxifen: From breast cancer therapy to the design of a postmenopausal prevention maintenance therapy
- 1 January 1997
- journal article
- review article
- Published by Springer Nature in Osteoporosis International
- Vol. 7 (1) , 52-57
- https://doi.org/10.1007/bf01674814
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- A realistic clinical perspective of tamoxifen and endometrial carcinogenesisEuropean Journal Of Cancer, 1996
- Effect of oestrogen during menopause on risk and age at onset of Alzheimer's diseaseThe Lancet, 1996
- Hormones, mood, and cognitive functioning in postmenopausal womenObstetrics & Gynecology, 1996
- Endometrial cancer. Management of high risk and recurrence including the tamoxifen controversyCancer, 1995
- The epidemiology of coronary heart disease and estrogen replacement in postmenopausal womenProgress in Cardiovascular Diseases, 1995
- A current view of tamoxifen for the treatment and prevention of breast cancerBritish Journal of Pharmacology, 1993
- Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast CancerNew England Journal of Medicine, 1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Effects of Tamoxifen on Cardiovascular Risk Factors in Postmenopausal WomenAnnals of Internal Medicine, 1991
- Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee.BMJ, 1991